INITIAL combination therapy with vildagliptin/metformin in drug-naive Asian type 2 diabetes patients: influence of age, BMI and co-morbidities in a real world setting

被引：0
|
作者：
Mirasol, R. C. [1 ]
Pathan, M. F. [2 ]
Chawla, M. [3 ]
Kim, T. H. [4 ]
Cooke, K. [5 ]
Hours-Zesiger, P. [5 ]
Shete, A. [5 ]
机构：
[1] St Lukes Med Ctr, Quezon City, Philippines
[2] BIRDEM Hosp, Dhaka, Bangladesh
[3] LINA Diabet Care Ctr, Mumbai, Maharashtra, India
[4] Seoul Med Ctr, Seoul, South Korea
[5] Novartis Pharma AG, Basel, Switzerland
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
774
引用
收藏
页码：S355 / S355
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of linagliptin/metformin fixed-dose combination as initial therapy in drug-naive Asian patients with type 2 diabetes
    Gong, Y.
    Mu, Y.
    Fan, B.
    Hehnke, U.
    Pan, C.
    DIABETOLOGIA, 2015, 58 : S388 - S388
  • [2] Efficacy and safety of linagliptin/metformin single-pill combination as initial therapy in drug-naive Asian patients with type 2 diabetes
    Mu, Yiming
    Pan, Changyu
    Fan, Bei
    Hehnke, Uwe
    Zhang, Xiuzhen
    Zhang, Xuejun
    Wang, Xiaoyue
    Liu, Jingdong
    Zhang, Ying
    Du, Jianling
    Ma, Jianhua
    Gong, Yan
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 124 : 48 - 56
  • [3] Initial Combination Therapy with Metformin Plus Colesevelam in Drug-Naive Hispanic Patients with Early Type 2 Diabetes
    Rosenstock, Julio
    Hernandez-Triana, Eric
    Handelsman, Yehuda
    Misir, Soamnauth
    Jones, Michael R.
    Nagendran, Sukumar
    POSTGRADUATE MEDICINE, 2012, 124 (04) : 7 - 13
  • [4] Initial Combination Therapy With Alogliptin and Pioglitazone in Drug-Naive Patients With Type 2 Diabetes
    Rosenstock, Julio
    Inzucchi, Silvio E.
    Seufert, Jochen
    Fleck, Penny R.
    Wilson, Craig A.
    Mekki, Qais
    DIABETES CARE, 2010, 33 (11) : 2406 - 2408
  • [5] Efficacy of vildagliptin in drug-naive patients with type 2 diabetes
    Dejager, S.
    Baron, M. A.
    Razac, S.
    Foley, J. E.
    Dickinson, S.
    Schweizer, A.
    DIABETOLOGIA, 2006, 49 : 479 - 480
  • [6] Efficacy and safety of gemigliptin/metformin initial combination therapy versus either as monotherapy in drug-naive patients with type 2 diabetes
    Lim, S.
    Min, K.
    Yu, J. -M.
    Chamnan, P.
    Kim, E.
    Yoon, K. -H.
    Kwon, S.
    Moon, M.
    Lee, K.
    Kim, D. -J.
    Kim, M.
    Wongtanate, M.
    Kim, E.
    Kim, S. -H.
    Lee, M. -K.
    DIABETOLOGIA, 2015, 58 : S54 - S54
  • [7] Initial combination of metformin, sitagliptin, and empagliflozin in drug-naive patients with type 2 diabetes: Safety and metabolic effects
    Lim, Soo
    Sohn, Minji
    Shin, Yujin
    Ferrannini, Ele
    DIABETES OBESITY & METABOLISM, 2022, 24 (04): : 757 - 762
  • [8] Initial Combination Therapy With Canagliflozin Plus Metformin Versus Each Component as Monotherapy for Drug-Naive Type 2 Diabetes
    Rosenstock, Julio
    Chuck, Leonard
    Gonzalez-Ortiz, Manuel
    Merton, Kate
    Craig, Jagriti
    Capuano, George
    Qiu, Rong
    DIABETES CARE, 2016, 39 (03) : 353 - 362
  • [9] Effects of gemigliptin versus sitagliptin or glimepiride on glycaemic variability as initial combination therapy with metformin in drug-naive patients with type 2 diabetes
    Lee, B. -W.
    Kim, J.
    Park, S.
    Jung, C.
    Lee, S. -H.
    Suh, S.
    Lee, W.
    Cho, J. -H.
    Jang, Y.
    Kim, S. -H.
    Park, C. -Y.
    DIABETOLOGIA, 2015, 58 : S387 - S387
  • [10] EFFECTS OF GEMIGLIPTIN VERSUS SITAGLIPTIN OR GLIMEPIRIDE ON GLYCEMIC VARIABILITY AS INITIAL COMBINATION THERAPY WITH METFORMIN IN DRUG-NAIVE PATIENTS WITH TYPE 2 DIABETES
    Park, S. E.
    Lee, B. -W.
    Kim, J. H.
    Jung, C. H.
    Lee, S. -H.
    Suh, S. H.
    Lee, W. J.
    Jang, Y. H.
    Kim, S. -H.
    Park, C. -Y.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S139 - S139
12345